Vanguard Group’s Nautilus Biotechnolgy NAUT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.8M | Sell |
2,485,081
-287,627
| -10% | -$209K | ﹤0.01% | 3568 |
|
|
2025
Q1 | $2.39M | Sell |
2,772,708
-5,741
| -0.2% | -$4.94K | ﹤0.01% | 3436 |
|
|
2024
Q4 | $4.67M | Buy |
2,778,449
+12,106
| +0.4% | +$20.3K | ﹤0.01% | 3300 |
|
|
2024
Q3 | $7.88M | Buy |
2,766,343
+42,747
| +2% | +$122K | ﹤0.01% | 3072 |
|
|
2024
Q2 | $6.37M | Sell |
2,723,596
-135,806
| -5% | -$318K | ﹤0.01% | 3143 |
|
|
2024
Q1 | $8.41M | Buy |
2,859,402
+29,604
| +1% | +$87K | ﹤0.01% | 3056 |
|
|
2023
Q4 | $8.46M | Buy |
2,829,798
+21,613
| +0.8% | +$64.6K | ﹤0.01% | 3045 |
|
|
2023
Q3 | $8.87M | Buy |
2,808,185
+6,279
| +0.2% | +$19.8K | ﹤0.01% | 2946 |
|
|
2023
Q2 | $10.8M | Sell |
2,801,906
-38,295
| -1% | -$148K | ﹤0.01% | 2899 |
|
|
2023
Q1 | $7.87M | Buy |
2,840,201
+664,825
| +31% | +$1.84M | ﹤0.01% | 3070 |
|
|
2022
Q4 | $3.92M | Sell |
2,175,376
-1,313
| -0.1% | -$2.36K | ﹤0.01% | 3420 |
|
|
2022
Q3 | $4.61M | Sell |
2,176,689
-3,631
| -0.2% | -$7.7K | ﹤0.01% | 3372 |
|
|
2022
Q2 | $5.87M | Sell |
2,180,320
-171,615
| -7% | -$462K | ﹤0.01% | 3290 |
|
|
2022
Q1 | $10.2M | Buy |
2,351,935
+1,066,638
| +83% | +$4.63M | ﹤0.01% | 3137 |
|
|
2021
Q4 | $6.66M | Buy |
1,285,297
+699,435
| +119% | +$3.62M | ﹤0.01% | 3451 |
|
|
2021
Q3 | $3.6M | Buy |
+585,862
| New | +$3.6M | ﹤0.01% | 3834 |
|